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Abstract 
In the winter of 2014–2015, a novel norovirus (NoV) strain (GII.17) was reported to be the major cause of gastroenteri-
tis outbreaks in East Asia. To determine the time course of gastroenteritis infections associated with the GII.17 strain 
and whether GII.17 was the main epidemic strain in diarrheal patients in Shanghai, 2169 stool samples were collected 
and tested. The detection rate of NoV GI and GII NoV strains was 0.83 and 24.02%, respectively. Phylogenetic analysis 
confirmed that there were seven NoV genotypes, among which GII.4 and GII.17 were the main genotypes. The GII.17 
strain was first detected in a sample collected on August 14th, 2014, and beginning in January 2015, the novel GII.17 
strain replaced the GII.4 strain as the dominant NoV genotype causing acute gastroenteritis in patients in Shanghai.
© The Author(s) 2016. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Norovirus (NoV) is a leading cause of diarrhea inpatients 
of all age groups with acute gastroenteritis worldwide [1]. 
Starting in November 2014, Guangdong [2], Jiangsu [3], 
and Zhejiang [4] in China, and Japan [5] reported diar-
rheal disease outbreaks that were caused by a novel NoV 
genotype GII.17. Chen et al. [6] reported this novel geno-
type collected from sporadic patients in Shanghai during 
the winter of 2014–2015 has evolutionary relationships 
with other reported genotypes [2, 5]. Here, we charac-
terized the molecular epidemiology of NoV infections in 
Shanghai between July 2014 and June 2015 to examine 
when did this novel NoV genotype strain begin to preva-
lent and whether the NoV GII.4 is still the leading NoV 
genotype in Shanghai, China.
A total of 2169 stool samples were collected from 
18,669 diarrheal patients, reported to the syndromic sur-
veillance network from 12 sentinel hospitals, between 
July 2014 and June 2015. The detection rate of the NoV 
GI and GII was 0.83% (18/2169) and 24.02% (521/2169) 
by real-time reverse transcription polymerase chain reac-
tion (qRT-PCR), respectively.
Partial nucleotide sequences of the NoV GII ORF2 
gene was amplified. Genotypes were determined using 
Norovirus Genotyping Tool Version 1.0. The numbers 
of strains corresponding to the GII.2, GII.3, GII.4, GII.6, 
GII.13, GII.17 and GII.21 strains were 3, 5, 133, 3, 8, 286 
and 10, respectively. GII.17 (63.84%, 286/448) and GII.4 
(29.69%, 133/448) were the most prevalent NoV GII gen-
otypes between July 2014 and January 2015.
NoV infections occurred in all seasons and peaked 
between October 2014 and April 2015 (Fig. 1). The novel 
genotype GII.17 strain was first detected in a 24-year-old 
female patient on August 14th, 2014 in Shanghai. Begin-
ning in January 2015, GII.17, which clustered to the novel 
variant Kawasaki_2014, was the most prevalent genotype 
of NoV GII, replacing GII.4 as the most prevalent NoV 
genotype in Shanghai. After May 2015, the GII.4 strain 
was rarely detected (Fig. 1).
As the most prevalent strain, the GII.4 genotype Syd-
ney_2012 and its variants were surveyed and reported 
globally [7–12], beginning in 2012 [13]. However, start-
ing in November 2014, a novel NoV genotype GII.17 
was reported to cause diarrheal disease outbreaks, 
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worldwidely [2, 5, 14–16] and Matesushiam et  al. 
[5] found that this novel genotype had a polymerase 
sequence and amino acid substitutions in the capsid 
region. In this study, we reported that the GII.17 geno-
type was first detected in diarrheal patients in August 
2014, which was earlier than the first reported outbreak 
in Jiangsu [3]. Similar with the findings by Chen et  al. 
[6], the GII.17 genotype became the predominant geno-
type beginning in November 2014 (Fig. 2). Our findings 
demonstrate that beginning in December 2014, GII.17 
replaced GII.4 as the most prevalent NoV genotype in 
Shanghai. Teasing out viral, environmental, or host spe-
cific factors should be investigated to understand emer-
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Fig. 2 Phylogenetic analysis of partial capsid region (ORF2) of NoV strains. Presented is a cladogram with supporting bootstrap values with full 
length VP1 nucleotide of reference NoVs according to LeBlanc et al. [15]. Representative strain from acute diarrheal patients in Shanghai, 2014–2015 
are shown with black circle
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performed to verify whether this novel genotype would 
be prevalent continuously.
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